These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4367375)

  • 1. Effect of histone on oncogenic properties of Moloney's murine sarcoma virus.
    Balandin IG; Tatarinova YuN ; Amchenkova AM; Koltsov VD; Krimskaja LL; Lushnikov AA
    Arch Gesamte Virusforsch; 1973; 43(1):1-6. PubMed ID: 4367375
    [No Abstract]   [Full Text] [Related]  

  • 2. Murine leukemia and sarcoma viruses: further studies on the antigens of the viral envelope.
    Gomard E; Leclerc JC; Levy JP
    J Natl Cancer Inst; 1973 Apr; 50(4):955-61. PubMed ID: 4122212
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 4. [The stimulating influence of histone on the oncogenicity of Moloney mouse sarcoma virus in vivo].
    Tatarinova IuN; Kol'tsov VD; Lushnikov AA; Krymskaia LL; Amchenkova AM
    Vopr Virusol; 1972; 17(4):486-90. PubMed ID: 5086861
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tissue injury on tumorigenesis induced by murine sarcoma virus (Harvey).
    Thomas WR; Aw EJ; Papadimitriou JM; Simons PJ
    J Natl Cancer Inst; 1974 Sep; 53(3):763-6. PubMed ID: 4369962
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses.
    Chirigos MA; Perk K; Turner W; Burka B; Gomez M
    Cancer Res; 1968 Jun; 28(6):1055-63. PubMed ID: 5658439
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunobiological studies of tumors induced by murine sarcoma virus (Kirsten).
    McCoy JL; Fefer A; McCoy NT; Kirsten WH
    Cancer Res; 1972 Feb; 32(2):343-9. PubMed ID: 4333497
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenicity of a virus-induced murine sarcoma (Moloney).
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 May; 27(5):962-7. PubMed ID: 4290556
    [No Abstract]   [Full Text] [Related]  

  • 10. The humoral antibody response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW; Klein E; Andersson B; Fenyö EM; Skurzak HM
    Int J Cancer; 1973 Nov; 12(3):637-45. PubMed ID: 4364795
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of hamster-specific oncogenic virus derived from hamster tumors induced by Kirsten murine sarcoma virus.
    Sarma PS; Log T; Gilden RV
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):718-22. PubMed ID: 4313154
    [No Abstract]   [Full Text] [Related]  

  • 12. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic, virologic, and pathologic studies of regression of autochthonous Moloney sarcoma virus-induced tumors in mice.
    Fefer A; McCoy JL; Perk K; Glynn JP
    Cancer Res; 1968 Aug; 28(8):1577-85. PubMed ID: 4876979
    [No Abstract]   [Full Text] [Related]  

  • 15. Naturally occurring sarcoma virus of the BALB/cCr mouse.
    Peters RL; Rabstein LS; VanVleck R; Kelloff GJ; Huebner RJ
    J Natl Cancer Inst; 1974 Dec; 53(6):1725-9. PubMed ID: 4373578
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic control of oncogenesis by murine sarcoma virus Moloney pseudotype. I. Genetics of resistance in AKR mice.
    Colombatti A; Collavo D; Biasi G; Chieco-Bianchi L
    Int J Cancer; 1975 Sep; 16(3):427-34. PubMed ID: 170219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW; Skurzak HM; Klein E
    Int J Cancer; 1972 Nov; 10(3):581-8. PubMed ID: 4128689
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune response to sarcomas. A review.
    Weinert CR; McMaster JH; Ferguson RJ
    Clin Orthop Relat Res; 1974; (102):207-16. PubMed ID: 4529323
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus.
    Stutman O
    Nature; 1975 Jan; 253(5487):142-4. PubMed ID: 1110765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.